Group items matching

in title, tags, annotations or url

Amidst the pervasive prevalence of pain, with 93% of the global populace experiencing it annually and 1 in 3 enduring daily discomfort, there persists a reluctance to address and treat pain proactively. This leads to a heightened burden of suffering among individuals. Join us for an enlightening 1-hour Pain Management Webinar, meticulously crafted to equip you and your team with vital strategies to comprehend, manage, and alleviate pain in patients' daily lives. Delve into topics such as the pharmacist's evolving role, understanding pain assessment, and Haleon's #ListenToPain campaign, aimed at fostering better patient conversations. Tailored for pharmacists in GB dealing with acute or chronic pain, this webinar promises to enhance patient care and contribute positively to their well-being. Don't miss out on this opportunity to make a meaningful difference. Register now to secure your spot at this impactful event!

Wes Streeting MP has been appointed Secretary of State for Health and Social Care in the new Labour Government. The Ilford North MP will now take on the critical role of overseeing the National Health Service (NHS) and implementing Labour's ambitious health agenda. At the core of the Labour Party's healthcare reform manifesto is enhancing accessibility to primary and community healthcare. This involves implementing a 'Community Pharmacist Prescribing Service,' to empower pharmacists with independent prescribing rights where clinically suitable. This initiative aims to alleviate the strain on GP practices and enhance service accessibility. Additionally, the manifesto proposes piloting Neighbourhood Health Centres, to integrate various healthcare services -such as family doctors, district nurses, and mental health specialists under one roof.

"Barcodes are becoming obsolete, so we needed a unique selling point," comments Business Development Manager at Huxley Europe, Richard Wertheimer, celebrating the relaunch of its HuxQ10 capsules. Now boasting a rare triple certification, HuxQ10 capsules are Halal approved by Halal Trust, Kosher approval by Rabbi Adler, and certification as vegan. This milestone marks a significant step for the company, making HuxQ10 accessible to a wider audience. Coenzyme Q10, or Q10, is a naturally occurring vitamin-like substance in the body, playing a crucial role in mitochondrial biogenetics and ATP production, which is vital for cellular energy. It also acts as a powerful antioxidant, capable of regenerating alpha-tocopherol, the active form of vitamin E.

Recognising the changing practices in healthcare, the Royal Pharmaceutical Society (RPS) has revised and updated its position on the separation of prescribing and dispensing or administration of a medicine by the same healthcare professional. It's previous guidance, published in March 2020, restricted prescribing and dispensing by the same healthcare professional only in exceptional circumstances. The new guidance, jointly developed with the Royal College of Nursing (RCN), has made prescribing and dispensing of medicines more flexible. It clarifies that "where there is a risk assessment in place and in the best interests of the patient, the same healthcare professional can be responsible for the prescribing and dispensing / supply / administration of medicines." The change in the position statement follows an extensive year-long engagement exercise with medical associations, members, fellows, expert advisory groups, patient groups and the RPS Country Boards.

In a significant move aimed at improving patient care and alleviating hospital pressures, the National Health Services (NHS) has expanded its same day emergency care services across the UK. This has resulted in thousands more individuals receiving rapid tests and treatment, effectively avoiding overnight hospital stays. Recent data paints a promising picture, revealing an 11 per cent increase in the number of patients discharged on the same day they were admitted as emergencies. This advancement translates to several patients receiving urgent care within hours, subsequently freeing up beds for others in need. Over the past year alone, an impressive 206,446 more patients have been discharged on the same day, amounting to 2,024,129 individuals in the year leading up to January 2024, compared to 1,817,683 in the preceding year. The successful rollout of same day emergency care to every hospital in England has played a pivotal role in easing bed congestion and reducing hospital admissions by up to 30 per cent in certain NHS Trusts.

Trainee pharmacists across Great Britain are preparing to participate in Pharmacist Support's annual Trainee ACTNow Wellbeing Campaign, scheduled from May 20th to 24th. Organised by the charity, this initiative aims to provide essential support as trainees approach the culmination of their placements and gear up for the General Pharmaceutical Council (GPhC) assessment. Danielle Hunt, Chief Executive of Pharmacist Support, highlighted the campaign's focus on addressing the significant stress and pressure trainees may experience during this critical period. She stated: "We understand the anxiety and pressure they may feel, not only in preparing for the assessment but also in stepping into their roles as registered pharmacists."

The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK Country Manager at Viatris, as its new Vice-Chair with immediate effect. He will replace the current chair of the BGMA, Diane DiGangi-Trench, who is the UK country head for Sandoz. Salzman, who is originally from Australia, has served approximately 1 billion patients worldwide last year as the UK Country Manager at Viatris, a global pharmaceutical company operating in 165 countries. In his role as BGMA Vice-Chair, Salzmann would focus on working in partnership with key stakeholders - the NHS, healthcare professionals, policy makers, clinical societies, patient associations, academia - to ensure access to affordable and sustainable medicines for patients and the NHS.

Erectile dysfunction (ED), also known as impotence, is characterized by the consistent or recurrent inability to achieve and/or maintain an erection sufficient for sexual intercourse. It becomes increasingly common with age, affecting approximately 50 - 55 per cent of men aged between 40 and 70 years. ED is estimated to affect up to three-quarters of men globally, and by 2025, 322 million men are expected to experience it. Research indicates that erectile dysfunction is highly prevalent in the UK, affecting over a quarter of younger men. Among Brits with ED, cardiometabolic and psychological conditions were frequently observed. Despite the high prevalence of erectile dysfunction among men, it remains poorly understood, underdiagnosed, and undertreated.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Anastrozole in a new use to prevent the disease. The off-patent drug has been used as a breast cancer treatment for many years. Clinical trials have shown that it can reduce the incidence of breast cancer in post-menopausal women with increased risk by almost 50 per cent. Health Minister Will Quince expressed his happiness on the approval of the drug that can help to prevent this "cruel disease". He said: "We've already seen the positive effect Anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women.